CONSOLIDATED STATEMENTS OF NET INCOME (unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
CONSOLIDATED STATEMENTS OF NET INCOME (unaudited) [Abstract]
Net patient revenues	$ 96,273	$ 86,411	$ 287,584	$ 259,893
Other revenues	6,759	1,933	17,264	5,789
Net revenues	103,032	88,344	304,848	265,682
Operating costs:
Salaries and related costs	60,306	49,868	174,912	146,509
Rent, supplies, contract labor and other	20,600	17,885	60,720	52,938
Provision for doubtful accounts	930	917	2,716	2,962
Closure costs	4	9	27	54
Total operating costs	81,840	68,679	238,375	202,463
Gross margin	21,192	19,665	66,473	63,219
Corporate office costs	8,304	7,610	25,707	24,640
Operating income	12,888	12,055	40,766	38,579
Interest and other income, net	11	21	58	62
Interest expense:
Mandatorily redeemable non-controlling interests - change in redemption value	(1,247)	(1,934)	(7,839)	(6,056)
Mandatorily redeemable non-controlling interests - earnings allocable	(1,285)	(929)	(4,366)	(3,146)
Debt and other	(641)	(326)	(1,572)	(954)
Total interest expense	(3,173)	(3,189)	(13,777)	(10,156)
Income before taxes	9,726	8,887	27,047	28,485
Provision for income taxes	3,132	2,753	8,029	8,727
Net income	6,594	6,134	19,018	19,758
Less: net income attributable to non-controlling interests	(1,444)	(1,330)	(4,111)	(4,454)
Net income attributable to USPH shareholders	$ 5,150	$ 4,804	$ 14,907	$ 15,304
Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share)	$ 0.41	$ 0.38	$ 1.19	$ 1.22
Shares used in computation - basic (in shares)	12,581	12,520	12,563	12,494
Shares used in computation - diluted (in shares)	12,581	12,520	12,563	12,494
Dividends declared per common share (in dollars per share)	$ 0.20	$ 0.17	$ 0.60	$ 0.51